Changes in COX-2 and oxidative damage factors during differentiation of human mesenchymal stem cells to hepatocyte-like cells is associated with downregulation of P53 gene

Biological Chemistry

Volumn 394, Issue 9, 2013, Pages 1213-1222

  Khajeniazi, Safoura ^a   Allameh, Abdolamir ^a   Soleimani, Masoud ^a   Mortaz, Esmaeil ^b,c  

^a TARBIAT MODARES UNIVERSITY   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c UTRECHT UNIVERSITY   (Netherlands)

Author keywords

COX 2; Differentiation; Hepatocytes; Oxidative damage; P53; Stem cells

Indexed keywords

ALBUMIN; CYCLOOXYGENASE 2; MESSENGER RNA; PROTEIN P53;

ADIPOCYTE; ARTICLE; CELL DAMAGE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL TRANSDIFFERENTIATION; CONTROLLED STUDY; DNA DAMAGE; HUMAN; HUMAN CELL; LIPID OXIDATION; LIPID PEROXIDATION; LIVER CELL; MESENCHYMAL STEM CELL; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

CELL DIFFERENTIATION; CELL GROWTH PROCESSES; CYCLOOXYGENASE 2; DOWN-REGULATION; GENES, P53; HEPATOCYTES; HUMANS; MESENCHYMAL STROMAL CELLS; OXIDATIVE STRESS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84881538023     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/hsz-2012-0355     Document Type: Article

References (29)

1. Almog, N. and Rotter, V. (1997). Involvement of p53 in cell differentiation and Development. Biochim. Biophys. Acta 1333, 1 - 27.
2. Arikawa, T., Omura, K.M., and Morita, I. (2004). Regulation of bone morphogenetic protein-2 expression by endogenous prostaglandin E2 in human mesenchymal stem cells. J. Cell. Phys. 200, 400 - 406.
3. Chen, Q., Miyamura, C., Higashi, S., Murakami, M., Kudo, I., Saito, S., Hiraide, T., Shibasaki, Y., and Suda, T. (1997). Activation of cytosolic phospholipase A2 by platelet-derived growth factor is essential for cyclooxygenase-2-dependent prostaglandin E2 synthesis in mouse osteoblasts cultured with interleukin-1. J. Biol. Chem. 272, 5952 - 5958.
4. Choi, E.M., Heob, J.I., Oha, J.Y., Kima, Y.M., Haa, K.S., Kim, J.I., and Han, J.A. (2005). COX-2 regulates p53 activity and inhibits DNA damage-induced apoptosis. Biochem. Biophys. Res. Commun. 328, 1107 - 1112.
5. Ghaderi, M., Allameh, A., Soleimani, M., Rastegar, H., and Ahmadi-Ashtiania, H.R. (2011). A comparison of DNA damage induced by aflatoxin B1 in hepatocyte-like cells, their progenitor mesenchymal stem cells and CD34 + cells isolated from umbilical cord blood. Mutat. Res. 719, 14 - 20.
6. Han, J.A., Kim, J.I., Ongusaha, P.P., Hwang, D.H., Ballou, L.R., Mahale, A., Aaronson, S.A., and Lee, S.W. (2002). p53-mediated induction of COX-2 counteracts p53- or genotoxic stress-induced apoptosis. EMBO J. 21, 5635 - 5644.
7. Hirano, T. and Tamae, K. (2012). Differentiation of embryonic stem cells and oxidative DNA damage/DNA repair systems. J. Stem. Cell Res. Ther. 10, 1-5.
8. Ito, K., Hirao, A., Arai, F., Takubo, K., Matsuoka, S., Miyamoto, K., Ohmura, M., Naka, K., Hosokawa, K., Ikeda, Y., et al. (2006). Reactive oxygen species act through p38 MAPK to limit the lifespan of hematopoietic stem cells. Nat. Med. 12, 446 - 451.
9. Ji, A.R., Ku, S.Y., Cho, M.S., Kim, Y.Y., Kim, Y.J., Oh, S.K., Kim, S.H., Moon, S.Y., and Choi, Y.M. (2010). Reactive oxygen species enhance differentiation of human embryonic stem cells into mesendodermal lineage. Exp. Mol. Med. 42, 175 - 186.
10. Jung, Y., Wang, J., Song, J., Shiozawa, Y., Wang, J., Havens, A., Wang, Z., Sun, Y., Emerson, S., Krebsbach, P., et al. (2007). Annexin II expressedby osteoblasts and endothelial cells regulates stem cell adhesion, homing, and engraftment following transplantation. Blood 110, 82 - 90.
11. Kanda, Y., Hinata, T., Sang, W.K., and Watanabe, Y. (2011). Reactive oxygen species mediate adipocyte differentiation in mesenchymal stem cells. Life Sciences 89, 250 - 258.
12. Kawaguchi, H., Pilbeam, C.C., Gronowicz, G., Abreu, C., Fletcher, B.S., Herschman, H.R., Raisz, L.G., and Hurley, M.M. (1995). Transcriptional induction of prostaglandin G/H synthase-2 by basic fibroblast growth factor. J. Clin. Invest. 96, 923 - 930.
13. Kazemnejad, S., Allameh, A., Soleimani, M., Gharehbaghian, A., Mohammadi, Y., Amirizadeh, N., and Jazayeri, M. (2008). Functional hepatocyte-like cells derived from human bone marrow mesenchymal stem cells on a novel 3-dimensional biocompatible nanofibrous scaffold. Int. J. Artif. Organs 31, 500 - 507.
14. Kazemnejad, S., Allameh, A., Soleimani, M., Gharehbaghian, A., Mohammadi, Y., Amirizadeh, N., and Jazayeri, M. (2009). Biochemical and molecular characterization of hepatocyte-like cells derived from human bone marrow mesenchymal stem cells on a novel three-dimensional biocompatible nanofibrous scaffold. J. Gastroentrol. Hepatol. 24, 278 - 287.
15. Lee, O.H., Kwon, Y.I., Hong, H.D., Park, C.S, Lee, B.Y., and Kim, Y.C. (2009). Production of reactive oxygen species and changes in antioxidant enzyme activities during differentiation of 3T3-L1 adipocyte. J. Korean Soc. Appl. Biol. Chem. 52, 70 - 75.
16. Levine, A.J. (1997). p53, the cellular gatekeeper for growth and division. Cell 88, 323 - 331.
17. Li, M., He, Y., Dubois, W., Wu, X., Shi, J., and Huang, J. (2012). Distinct regulatory mechanisms and functions for p53-Activated and p53-repressed DNA damage response genes in embryonic stem cells. Molecular Cell 46, 30 - 42.
18. Qiu, Y., Wang, W., Wang, T., Liu, J., Sun, P., Qian, J., Jin, L., and Xia, Z. (2008). Genetic polymorphisms, messenger RNA expression of p53, p21, and CCND1, and possible links with chromosomal aberrations in Chinese vinyl chloride - exposed workers. Cancer Epidemiol. Biomarkers. Prev. 17, 2578.
19. Rhee, S.G. (1999). Redox signaling: hydrogen peroxide as intracellular messenger. Exp. Mol. Med. 31, 53 - 59.
20. Saretzki, G., Walter, T., Atkinson, S., Passos, J.F., Bareth, B., Keith, W.N., Stewart, R., Hoare, S., Stojkovic, M., Armstrong, L., et al. (2008). Downregulation of multiple stress defense mechanisms during differentiation of human embryonic stem cells. Stem Cells 26, 455 - 464.
21. Schmelter, M., Ateghang, B., Helmig, S., Wartenberg, M., and Sauer, H. (2006). Embryonic stem cells utilize reactive oxygen species as transducers of mechanical strain-induced cardiovascular differentiation. FASEB J. 20, 1182 - 1184.
22. Sheng, H., Shao, J., Morrow, J.D., Beauchamp, R.D., and Du Bois, R.N. (1998). Modulation of apoptosis and Bcl-2 expression by prostaglandin E 2 in human colon cancer cells. Cancer Res. 58, 362 - 366.
23. Smith, W., Garavito, R.M., and De Witt, D.L. (1996). Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2. J. Biol. Chem. 271, 33157 - 33160.
24. Valko, M., Leibfritz, D., Moncol, J., Cronin, M.T., Mazur, M., and Telser, J. (2007). Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell Biol. 39, 44 - 84.
25. Vogelstein, B., Lane, D., and Levine, A.J. (2000). Surfing the p53 network. Nature 408, 307 - 310.
26. Yamamoto, K., Arakawa, T., Ueda, N., and Yamamoto, S. (1995). Transcriptional roles of nuclear factor B and nuclear factorinterleukin- 6 in the tumor necrosis factor a-dependent induction of cyclooxygenase-2 in MC3T3-E1 cells. J. Biol. Chem. 270, 31315 - 31320.
27. Zambetti, G.P., Horwitz, E.M., and Schipani, E. (2006). Skeletons in the p53 tumor suppressor closet: genetic evidence that p53 blocks bone differentiation and development. J. Cell Biol. 172, 795 - 797.
28. Zhang, X., Schwarz, E.M., Young, D.A., Puzas, J.E., Rosier, R.N., and Regis, J.O.K. (2002). Cyclooxygenase-2 regulates mesenchymal cell differentiation into the osteoblast lineage and is critically involved in bone repair. J. Clin. Invest. 109, 1405 - 1415.
29. Zhang, X., Miao, X., Tan, W., Ning, B., Liu, Z., Hong, Y., Song, W., Guo, Y., Guo, Y., Zhang, Y., et al. (2005). Identification of functional genetic variants in cylooxygenase-2 and their association with risk of esophageal cancer. Gastroenterology 129, 565 - 576.